GEODE CAPITAL MANAGEMENT, LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 59 filers reported holding ARCUS BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$19,345,302
-7.4%
1,077,593
+4.7%
0.00%0.0%
Q2 2023$20,897,412
+17.1%
1,028,922
+5.2%
0.00%0.0%
Q1 2023$17,841,772
+91055.0%
978,167
+3.3%
0.00%
-33.3%
Q4 2022$19,573
-99.9%
946,473
+3.9%
0.00%
-25.0%
Q3 2022$23,841,000
+11.3%
911,358
+7.8%
0.00%
+33.3%
Q2 2022$21,422,000
-14.9%
845,395
+6.0%
0.00%0.0%
Q1 2022$25,170,000
-19.2%
797,542
+3.6%
0.00%
-25.0%
Q4 2021$31,142,000
+14.0%
769,512
-1.7%
0.00%0.0%
Q3 2021$27,309,000
+28.9%
783,176
+1.5%
0.00%
+33.3%
Q2 2021$21,186,000
+6.0%
771,554
+8.4%
0.00%0.0%
Q1 2021$19,979,000
+19.1%
711,522
+10.1%
0.00%0.0%
Q4 2020$16,772,000
+58.9%
646,091
+4.9%
0.00%
+50.0%
Q3 2020$10,555,000
-22.8%
615,854
+11.4%
0.00%
-33.3%
Q2 2020$13,673,000
+123.6%
552,689
+25.4%
0.00%
+50.0%
Q1 2020$6,116,000
-23.3%
440,641
-44.2%
0.00%
+100.0%
Q4 2019$7,978,000
+127.7%
789,988
+105.1%
0.00%0.0%
Q3 2019$3,504,000
+91.4%
385,087
+67.2%
0.00%
Q2 2019$1,831,000
-27.8%
230,355
+13.5%
0.00%
-100.0%
Q1 2019$2,535,000
-35.0%
202,995
-44.0%
0.00%0.0%
Q4 2018$3,902,000
+185.9%
362,344
+269.8%
0.00%
Q3 2018$1,365,000
+40.9%
97,979
+23.7%
0.00%
Q2 2018$969,00079,2310.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders